Japan’s SoftBank will invest $2 billion into struggling American chipmaker Intel, the two companies announced Monday.

Beyfortus (nirsevimab) is the only option that can offer RSV protection designed for all infants with proven high, sustained efficacy, favourable safety and public health impact demonstrated in the ...